Advertisement

Current Nutrition Reports

, Volume 3, Issue 4, pp 400–411 | Cite as

Gene-Lifestyle Interactions in Complex Diseases: Design and Description of the GLACIER and VIKING Studies

  • Azra Kurbasic
  • Alaitz Poveda
  • Yan Chen
  • Åsa Ågren
  • Elisabeth Engberg
  • Frank B. Hu
  • Ingegerd Johansson
  • Ines Barroso
  • Anders Brändström
  • Göran Hallmans
  • Frida Renström
  • Paul W. Franks
Public Health and Translational Medicine (PW Franks, Section Editor)

Abstract

Most complex diseases have well-established genetic and non-genetic risk factors. In some instances, these risk factors are likely to interact, whereby their joint effects convey a level of risk that is either significantly more or less than the sum of these risks. Characterizing these gene-environment interactions may help elucidate the biology of complex diseases, as well as to guide strategies for their targeted prevention. In most cases, the detection of gene-environment interactions will require sample sizes in excess of those needed to detect the marginal effects of the genetic and environmental risk factors. Although many consortia have been formed, comprising multiple diverse cohorts to detect gene-environment interactions, few robust examples of such interactions have been discovered. This may be because combining data across studies, usually through meta-analysis of summary data from the contributing cohorts, is often a statistically inefficient approach for the detection of gene-environment interactions. Ideally, single, very large and well-genotyped prospective cohorts, with validated measures of environmental risk factor and disease outcomes should be used to study interactions. The presence of strong founder effects within those cohorts might further strengthen the capacity to detect novel genetic effects and gene-environment interactions. Access to accurate genealogical data would also aid in studying the diploid nature of the human genome, such as genomic imprinting (parent-of-origin effects). Here we describe two studies from northern Sweden (the GLACIER and VIKING studies) that fulfill these characteristics.

Keywords

Lifestyle Genetics Genealogy Biobank Complex disease Scandinavia 

Notes

Acknowledgments

We are grateful to the study participants whose data have contributed to the GLACIER and VIKING Studies through the studies that comprise the Northern Sweden Health and Disease Study. We are also thankful for the work and expertise of the many investigators and support staff who collected and managed data and biomaterials within those studies. The VIKING and GLACIER Studies have been primarily funded by the Swedish Research Council, Novo Nordisk Foundation, Swedish Heart Lung Foundation, Albert Påhlsson Foundation and the Swedish Diabetes Association (all grants to PWF).

Compliance with Ethics Guidelines

Conflict of Interest

Azra Kurbasic declares that she has no conflict of interest.

Alaitz Poveda has received research support through a grant from the Basque Government.

Yan Chen declares that he has no conflict of interest.

Åsa Ågren declares that she has no conflict of interest.

Elisabeth Engberg declares that she has no conflict of interest.

Frank B. Hu declares that he has no conflict of interest.

Ingegerd Johansson declares that she has no conflict of interest.

Ines Barroso, along with her spouse, owns stock in GlaxoSmithKline and Incyte Corporation.

Anders Brändström declares that he has no conflict of interest.

Göran Hallmans declares that he has no conflict of interest.

Frida Renström declares that she has no conflict of interest.

Paul W. Franks declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of outstanding importance

  1. 1.•
    Langenberg C Sharp SJ, Franks PW, Scott RA, Deloukas P, Forouhi NG et al. Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study. PLoS Med. 2014;11(5). This paper describes the largest study of gene-lifestyle interactions in incident type 2 diabetes to date. The study found that genetic effects on diabetes are greater at a younger age and in leaner participants. No evidence of interaction with Mediterranean diet or physical activity were observed.Google Scholar
  2. 2.
    Ahmad S, Varga TV, Franks PW. Gene x environment interactions in obesity: the state of the evidence. Hum Hered. 2013;75(2–4):106–15.PubMedCrossRefGoogle Scholar
  3. 3.
    Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet. 2003;362(9392):1275–81.Google Scholar
  4. 4.
    Horner FA, Streamer CW. Effect of a phenylalanine-restricted diet on patients with phenylketonuria; clinical observations in three cases. J Am Med Assoc. 1956;161(17):1628–30.PubMedCrossRefGoogle Scholar
  5. 5.
     Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350(21):2129–39.Google Scholar
  6. 6.•
    Hatzikotoulas K, Gilly A, Zeggini E. Using population isolates in genetic association studies. Brief Funct Genomics. 2014. This paper describes statistical approaches to genetic analysis in heavily admixed populations.Google Scholar
  7. 7.•
    Tenesa A, Haley CS. The heritability of human disease: estimation, uses and abuses. Nat Rev Genet. 2013;14(2):139–49. This paper outlines appropriate ways of interpreting heritability estimates, and explains how heritability estimates are frequently misinterpreted.PubMedCrossRefGoogle Scholar
  8. 8.
    Mannucci E, Dicembrini I, Lauria A, Pozzilli P.  Is glucose control important for prevention of cardiovascular disease in diabetes? Diabetes Care. 2013;36 Suppl 2:S259–63.Google Scholar
  9. 9.
    Santana S, Recuero M, Bullido MJ, Valdivieso F, Aldudo J. Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging. 2012;33(2):430.e19. 33.Google Scholar
  10. 10.
    Ball MJ, Lukiw WJ, Kammerman EM, Hill JM. Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology. Alzheimers Dement. 2013;9(2):169–75.Google Scholar
  11. 11.
    Siscovick DS, Schwartz SM, Corey L, Grayston JT, Ashley R, Wang SP et al. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study. Circulation. 2000;102(19):2335–40.Google Scholar
  12. 12.
    Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med. 2009;361(3):255–63.Google Scholar
  13. 13.
    Global Lipids Genetics Consortium, Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274–83.Google Scholar
  14. 14.
    Moore LE, Brennan P, Karami S, Menashe I, Berndt SI, Dong LM et al. Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk. Cancer Res. 2009;69(20):8001–8.Google Scholar
  15. 15.
    Kawai M, Devlin MJ, Rosen CJ. Fat targets for skeletal health. Nat Rev Rheumatol. 2009;5(7):365–72.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Roodman GD. Osteoblast function in myeloma. Bone. 2011;48(1):135–40.PubMedCrossRefGoogle Scholar
  17. 17.
    Cho HJ, Cho HJ, Kim HS. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep. 2009;11(3):206–13.PubMedCrossRefGoogle Scholar
  18. 18.
    Nilson F, Moniruzzaman S, Andersson R. A comparison of hip fracture incidence rates among elderly in Sweden by latitude and sunlight exposure. Scand J Public Health, 2013.Google Scholar
  19. 19.
    Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013;88(7):720–55.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354(7):684–96.Google Scholar
  21. 21.
    Shapses SA, Manson JE. Vitamin D and prevention of cardiovascular disease and diabetes: why the evidence falls short. JAMA. 2011;305(24):2565–6.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Strohmaier S, Edlinger M, Manjer J, Stocks T, Bjorge T, Borena W et al.  Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can). PLoS One. 2013;8(1):e54242.Google Scholar
  23. 23.
    Ulmer H, Bjorge T, Concin H, Lukanova A, Manjer J, Hallmans G et al. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Gynecol Oncol. 2012;125(2):330–5.Google Scholar
  24. 24.
    Haggstrom C, Rapp K, Stocks T, Manjer J, Bjorge T, Ulmer H et al. Metabolic factors associated with risk of renal cell carcinoma. PLoS One. 2013;8(2):e57475.Google Scholar
  25. 25.
    Lindkvist B, Almquist M, Bjorge T, Stocks T, Borena W, Johansen D et al. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer Causes Control. 2013;24(1):107–16.Google Scholar
  26. 26.•
    Haggstrom C, Stocks T, Ulmert D, Bjorge T, Ulmer H, Hallmans G et al. Prospective study on metabolic factors and risk of prostate cancer. Cancer. 2012;118(24):6199–206. This study describes observational analyses linking features of the metabolic syndrome and prostate cancer in European adults. The study includes a cohort from the Northern Sweden Biobank, where the GLACIER and VIKING Studies are set.Google Scholar
  27. 27.
    Nagel G, Stocks T, Spath D, Hjartaker A, Lindkvist B, Hallmans G et al. Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Ann Hematol. 2012;91(10):1519–31.Google Scholar
  28. 28.
    Stocks T, Van Hemelrijck M, Manjer J, Bjorge T, Ulmer H, Hallmans G et al. Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension. 2012;59(4):802–10.Google Scholar
  29. 29.
    Pierce BL. Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence. Urol Oncol. 2012;30(5):735–43.PubMedCrossRefGoogle Scholar
  30. 30.
    Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38(3):320–3.Google Scholar
  31. 31.
    Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB et al. Recurrent R-spondin fusions in colon cancer. Nature. 2012;488(7413):660–4.Google Scholar
  32. 32.•
    Helgason A, Palsson S, Thorleifsson G, Grant SF, Emilsson V, Gunnarsdottir S et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet. 2007;39(2):218–25. This paper provides an eloquent example of how genetic association signals can be refined using pedigree-based data in a population isolate.Google Scholar
  33. 33.
    Koontz JI, Soreng AL, Nucci M, Kuo FC, Pauwels P, van Den Berghe H et al. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A. 2001;98(11):6348–53.Google Scholar
  34. 34.
    Stevens VL, Ahn J, Sun J, Jacobs EJ, Moore SC, Patel AV et al.  HNF1B and JAZF1 genes, diabetes, and prostate cancer risk. Prostate. 2010;70(6):601–7.Google Scholar
  35. 35.
    Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3(7):e115.Google Scholar
  36. 36.
    Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45(4):353–61. 361e1-2.Google Scholar
  37. 37.
    Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012;44(6):651–8.Google Scholar
  38. 38.
    Bonnefond A, Skrobek B, Lobbens S, Eury E, Thuillier D, Cauchi S et al. Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications. Nat Genet. 2013;45(9):1040–3.Google Scholar
  39. 39.••
    Hallmans G, Agren A, Johansson G, Johansson A, Stegmayr B, Jansson JH et al. Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions. Scand J Public Health Suppl. 2003;61:18–24. This paper describes the Northern Sweden Health and Disease Study, the collection of cohorts making up the Northern Sweden Biobank, within which the VIKING and GLACIER Studies are set.Google Scholar
  40. 40.
    Johansson G, Wikman A, Ahren AM, Hallmans G, Johansson I. Underreporting of energy intake in repeated 24-hour recalls related to gender, age, weight status, day of interview, educational level, reported food intake, smoking habits and area of living. Public Health Nutr. 2001;4(4):919–27.Google Scholar
  41. 41.••
    Johansson I, Hallmans G, Wikman A, Biessy C, Riboli E, Kaaks R. Validation and calibration of food-frequency questionnaire measurements in the Northern Sweden Health and Disease cohort. Public Health Nutr. 2002;5(3):487–96. This paper describes some of the dietary methods and available data in the GLACIER and VIKING Studies.Google Scholar
  42. 42.
    Sullivan M, Karlsson J, Bengtsson C, Furunes B, Lapidus L, Lissner L. "The Goteborg Quality of Life Instrument"–a psychometric evaluation of assessments of symptoms and well-being among women in a general population. Scand J Prim Health Care. 1993;11(4):267–75.Google Scholar
  43. 43.
    Karasek R, Theorell T. Healthy work : stress, productivity, and the reconstruction of working life. New York: Basic Books; 1990.Google Scholar
  44. 44.
    Theorell T, Perski A, Akerstedt T, Sigala F, Ahlberg-Hulten G, Svensson J et al. Changes in job strain in relation to changes in physiological state. A longitudinal study. Scand J Work Environ Health. 1988;14(3):189–96.Google Scholar
  45. 45.
    Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG, World Health Organization. Dept. of Mental Health and Substance Dependence. AUDIT : the Alcohol Use Disorders Identification Test : guidelines for use in primary health care. 2nd ed. Geneva: World Health Organization; 2001. 38 p.Google Scholar
  46. 46.
    Aertgeerts B, Buntinx F, Kester A. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. J Clin Epidemiol. 2004;57(1):30–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, Chines PS et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 2012;8(8):e1002793.Google Scholar
  48. 48.
    Einarsdottir E, Egerbladh I, Beckman L, Holmberg D, Escher SA. The genetic population structure of northern Sweden and its implications for mapping genetic diseases. Hereditas. 2007;144(5):171–80.Google Scholar
  49. 49.
    Vikström P, Edvinsson S, Brändström A. Longitudinal databases –sources for analyzing the life course: characteristics, difficulties and possibilities. Hist Comput. 2004;14:1–2.Google Scholar
  50. 50.
    Mandemakers, K, Dillon L. Best Practices with Large Databases on Historical Populations. Historical Methods, 2004. 37(1).Google Scholar
  51. 51.
    Nettleton JA, McKeown NM, Kanoni S, Lemaitre RN, Hivert MF, Ngwa J et al.  Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care. 2010;33(12):2684–91.Google Scholar
  52. 52.
    Kanoni S, Nettleton JA, Hivert MF, Ye Z, van Rooij FJ, Shungin D et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes. 2011;60(9):2407–16.Google Scholar
  53. 53.
    Nettleton JA, Hivert MF, Lemaitre RN, McKeown NM, Mozaffarian D, Tanaka T et al. Meta-analysis investigating associations between healthy diet and fasting glucose and insulin levels and modification by loci associated with glucose homeostasis in data from 15 cohorts. Am J Epidemiol. 2013;177(2):103–15.Google Scholar
  54. 54.
    Hruby A, Ngwa JS, Renstrom F, Wojczynski MK, Ganna A, Hallmans G et al. Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies. J Nutr. 2013;143(3):345–53.Google Scholar
  55. 55.
    Scott RA, Chu AY, Grarup N, Manning AK, Hivert MF, Shungin D et al. No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Diabetes. 2012;61(5):1291–6.Google Scholar
  56. 56.
    Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012;44(6):659–69.Google Scholar
  57. 57.
    Kilpelainen TO, Qi L, Brage S, Sharp SJ, Sonestedt E, Demerath E et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 2011;8(11):e1001116.Google Scholar
  58. 58.
    Varga TV, Hallmans G, Hu FB, Renstrom F, Franks PW. Smoking status, snus use, and variation at the CHRNA5-CHRNA3-CHRNB4 locus in relation to obesity: the GLACIER study. Am J Epidemiol. 2013;178(1):31–7.Google Scholar
  59. 59.
    Freathy RM, Kazeem GR, Morris RW, Johnson PC, Paternoster L, Ebrahim S et al. Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol. 2011;40(6):1617–28.Google Scholar
  60. 60.
    Ahmad S, Rukh G, Varga TV, Ali A, Kurbasic A, Shungin D et al. Gene x physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry. PLoS Genet. 2013;9(7):e1003607.Google Scholar
  61. 61.
    Li S, Zhao JH, Luan J, Ekelund U, Luben RN, Khaw KT et al. Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study. PLoS Med, 2010. 7(8).Google Scholar
  62. 62.
    Tanaka T, Ngwa JS, van Rooij FJA, Zillikens MC, Wojczynski MK, Frazier-Wood AC et al. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. Am J Clin Nutr. 2013;97(6):1395–402.Google Scholar
  63. 63.
    Qi Q, Kilpelainen TO, Downer MK, Tanaka T, Smith CE, Sluijs I et al. FTO genetic variants, dietary intake and body mass index: insights from 177 330 individuals. Hum Mol Genet, 2014.Google Scholar
  64. 64.
    Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45(11):1345–52.Google Scholar
  65. 65.
    Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012;380(9841):572–80.Google Scholar
  66. 66.
    Consortium CAD, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45(1):25–33.Google Scholar
  67. 67.••
    Varga TV, Sonestedt E, Shungin D, Koivula RW, Hallmans G, Escher SA et al. Genetic determinants of long-term changes in blood lipid concentrations: 10-year follow-up of the GLACIER study. PLoS Genet. 2014;10(6):e1004388. This paper provides a detailed description of the GLACIER Study and reports data on the association of gene variants at 157 loci and long-term deteriorations in blood lipid concentrations in people from Northern Sweden.Google Scholar
  68. 68.
    Franks PW, Rolandsson O, Debenham SL, Fawcett KA, Payne F, Dina C et al. Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia. 2008;51(3):458–63.Google Scholar
  69. 69.
    Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham SL, Daly A et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet. 2007;39(8):951–3.Google Scholar
  70. 70.
    Fawcett KA, Wheeler E, Morris AP, Ricketts SL, Hallmans G, Rolandsson O et al. Detailed investigation of the role of common and low-frequency WFS1 variants in type 2 diabetes risk. Diabetes. 2010;59(3):741–6.Google Scholar
  71. 71.
    Fontaine-Bisson B, Renstrom F, Rolandsson O, Magic, Payne F, Hallmans G et al. Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population. Diabetologia. 2010;53(10):2155–62.Google Scholar
  72. 72.
    Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105–16.Google Scholar
  73. 73.••
    Renstrom F, Shungin D, Johansson I, Investigators M, Florez JC, Hallmans G et al. Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study. Diabetes. 2011;60(1):345–54. This paper provides a detailed description of the GLACIER Study and reports data on the association of gene variants at 16 loci and long-term deteriorations in blood glucose concentrations in people from Northern Sweden.Google Scholar
  74. 74.
    Albrechtsen A, Grarup N, Li Y, Sparso T, Tian G, Cao H et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia. 2013;56(2):298–310.Google Scholar
  75. 75.
    Renstrom F, Payne F, Nordstrom A, Brito EC, Rolandsson O, Hallmans G et al. Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden. Hum Mol Genet. 2009;18(8):1489–96.Google Scholar
  76. 76.
    Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–90.Google Scholar
  77. 77.
    Lindgren CM, Heid IM, Randall JC, Lamina C, Steinthorsdottir V, Qi L et al. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet. 2009;5(6):e1000508.Google Scholar
  78. 78.
    Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet. 2013;45(5):501–12.Google Scholar
  79. 79.
    Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL et al. Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 2013;9(6):e1003500.Google Scholar
  80. 80.
    Kong A, Masson G, Frigge ML, Gylfason A, Zusmanovich P, Thorleifsson G et al. Detection of sharing by descent, long-range phasing and haplotype imputation. Nat Genet. 2008;40(9):1068–75.Google Scholar
  81. 81.
    Styrkarsdottir U, Thorleifsson G, Sulem P, Gudbjartsson DF, Sigurdsson A, Jonasdottir A et al. Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature. 2013;497(7450):517–20.Google Scholar
  82. 82.
    Palotie A, Widen E, Ripatti S. From genetic discovery to future personalized health research. N Biotechnol, 2012.Google Scholar
  83. 83.
    Mott R, Yuan W, Kaisaki P, Gan X, Cleak J, Edwards A et al.  The architecture of parent-of-origin effects in mice. Cell. 2014;156(1–2):332–42.Google Scholar
  84. 84.
    Hoggart CJ, Venturini G, Mangino M, Gomez F, Ascari G, Zhao JH et al. Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index. PLoS Genet. 2014;10(7):e1004508.Google Scholar
  85. 85.
    Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG et al. The sequence of the human genome. Science. 2001;291(5507):1304–51.Google Scholar
  86. 86.
    Lander ES, Consortium IHGS, Linton LM, Birren B, Nusbaum C, Zody MC et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860–921.Google Scholar
  87. 87.
    Bennett ST, Barnes C, Cox A, Davies L, Brown C. Toward the 1,000 dollars human genome. Pharmacogenomics. 2005;6(4):373–82.Google Scholar
  88. 88.
    Mardis ER. Anticipating the 1,000 dollar genome. Genome Biol. 2006;7(7):112.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Azra Kurbasic
    • 1
  • Alaitz Poveda
    • 1
    • 2
  • Yan Chen
    • 1
  • Åsa Ågren
    • 3
  • Elisabeth Engberg
    • 4
  • Frank B. Hu
    • 5
  • Ingegerd Johansson
    • 6
  • Ines Barroso
    • 7
    • 8
    • 9
  • Anders Brändström
    • 4
  • Göran Hallmans
    • 3
    • 10
  • Frida Renström
    • 1
    • 3
  • Paul W. Franks
    • 1
    • 5
    • 10
  1. 1.Department of Clinical Sciences, Genetic and Molecular Epidemiology UnitLund University, Skåne University Hospital MalmöMalmöSweden
  2. 2.Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and TechnologyUniversity of the Basque CountryBilbaoSpain
  3. 3.Department of Biobank ResearchUmeå UniversityUmeåSweden
  4. 4.Umeå Demographic DatabaseUmeå UniversityUmeåSweden
  5. 5.Department of NutritionHarvard School of Public HealthBostonUSA
  6. 6.Department of OdontologyUmeå UniversityUmeåSweden
  7. 7.Wellcome Trust Sanger InstituteCambridgeUK
  8. 8.Metabolic Research Laboratories Institute of Metabolic Science, Addenbrooke’s HospitalUniversity of CambridgeCambridgeUK
  9. 9.NIHR Cambridge Biomedical Research Centre, Institute of Metabolic ScienceAddenbrooke’s HospitalCambridgeUK
  10. 10.Department of Public Health & Clinical MedicineUmeå UniversityUmeåSweden

Personalised recommendations